JP/ EN

COMPANY

Outline

Company Name
K Pharma, Inc.
Founded on
November 1st, 2016
Our Works
Research, development, manufacture and sales of regenerative medicine products
Research, development, manufacture and sales of pharmaceutical products
President and CEO
Komei Fukushima
Headquarters
Tri-Seven Roppongi 8F, 7-7-7 Roppongi, Minato-ku, Tokyo 106-0032, Japan

Management

Directors

  • アイキャッチ画像

    Komei Fukushima

    President and CEO

    アイキャッチ画像

    President and CEO

    Komei Fukushima
    1988
    Eisai Co., Ltd.
    2006
    Eisai Research Institute of Boston,Inc.
    2014
    Lecturer, Department of Physiology, Keio University School of Medicine
    2015
    Project Associate Professor, Department of Physiology, Keio University School of Medicine (present)
    2016
    President and Chief Executive Officer (Representative Director), K Pharma Inc. (present)
  • アイキャッチ画像

    Hideyuki Okano

    CSO

    アイキャッチ画像

    CSO

    Hideyuki Okano
    1983
    Instructor, Department of Physiology, Keio University School of Medicine
    1985
    Instructor, Institute for Protein Research, Osaka University
    1989
    Postdoctoral Research Fellow, Department of Biological Chemistry, The Johns Hopkins University School of Medicine
    1991
    Instructor, Institute for Protein Research, Osaka University
    1992
    Instructor, Department of Molecular Neurobiology, Institute of Medical Science, University of Tokyo
    1994
    Professor, Department of Molecular Neurobiology, Institute of Basic Medical Sciences, University of Tsukuba
    1997
    Professor, Division of Neuroanatomy, Department of Neuroscience, Osaka University Graduate School of Medicine
    2001
    Professor, Department of Physiology, Keio University School of Medicine
    2007
    Dean, Keio University Graduate School of Medicine
    2008
    Visiting Professor, University of Queensland
    2015
    Dean, Keio University School of Medicine
    2019
    Director, K Pharma Inc. (present)
    2021
    President, The Japanese Society for Regenerative Medicine (JSRM) (present)
    2022
    Visiting Professor, Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology (present)
    2023
    Vice President, International Society for Stem Cell Research (ISSCR)
    2024
    Distinguished Professor and Director, Keio University Regenerative Medicine Research Center (present)
    2024
    President Elect, International Society for Stem Cell Research (ISSCR) (present)
  • アイキャッチ画像

    Masaya Nakamura

    CTO

    アイキャッチ画像

    CTO

    Masaya Nakamura
    1998
    Research Fellow, Georgetown University
    2000
    Instructor, Department of Orthopaedic Surgery, Keio University School of Medicine
    2004
    Assistant professor, Department of Orthopaedic Surgery, Keio University School of Medicine
    2007
    Lecturer (part-time), Institute for Frontier Medical Sciences, Kyoto University
    2012
    Associate professor, Department of Orthopaedic Surgery, Keio University School of Medicine
    2015
    Professor & Chair, Department of Orthopaedic Surgery, Keio University School of Medicine (present)
    2017
    Assistant Dean, Keio University School of Medicine
    2019
    Executive Director, The Japanese Society for Regenerative Medicine (JSRM) (present)
    2019
    Director, K Pharma Inc. (present)
    2021
    Vice Dean, Keio University School of Medicine (present)
  • アイキャッチ画像

    Masato Matsumoto

    Managing Director and CFO

    アイキャッチ画像

    Managing Director and CFO

    Masato Matsumoto
    2001
    PwC Consulting (currently IBM Japan, Ltd.)
    2005
    Mizuho Investors Securities Co., Ltd. (currently Mizuho Securities Co., Ltd.)
    2012
    Mizuho Bank, Ltd.
    2013
    Cross Company (currently Stripe International Inc.)
    2016
    Director, Stripe International Inc.
    2021
    Director and Chief Financial Officer, K Pharma Inc.
    2024
    Managing Director and Chief Financial Officer, K Pharma Inc. (present)
  • アイキャッチ画像

    Keiko Hatta

    Outside Director

    アイキャッチ画像

    Outside Director

    Keiko Hatta
    1984
    Japan Airlines Co., Ltd.
    1991
    IBJ International Ltd.
    2009
    General Manager, Finance Department, JAL Capital Co., Ltd.
    2010
    Executive Officer & General Manager, Money Center, JAL Capital Co., Ltd.
    2010
    Senior Director, Finance, Japan Airlines International Co., Ltd.
    2013
    President, Hakko Inc. (present)
    2014
    Lecturer (part-time), Saitama Prefectural University
    2017
    Lecturer (part-time), Toita Women's College
    2020
    Outside Director, Teraoka Seisakusho Co., Ltd.
    2022
    Outside Director, K Pharma Inc. (present)
    2024
    Outside Director, IWATA & Co.,Ltd. (present)

Audit & Supervisory Board Members

  • Akiko Isohata

    Outside Audit & Supervisory Board Member

    Outside Audit & Supervisory Board Member

    Akiko Isohata
    2001
    Tokyo Hatchobori Law Office
    2011
    Partner, Tokyo Hatchobori Law Office (present)
    2022
    Outside Audit & Supervisory Board Member, K Pharma Inc. (present)
    2022
    Outside Audit & Supervisory Board Member, NEC Networks & System Integration Corporation (present)

  • Yasutaka Nishida

    Outside Audit & Supervisory Board Member

    Outside Audit & Supervisory Board Member

    Yasutaka Nishida
    2005
    Ernst & Young ShinNihon LLC
    2012
    President, Accounting Firm (present)
    2021
    Outside Audit & Supervisory Board Member, K Pharma Inc. (present)

  • Shunsuke Toyokawa

    Outside Audit & Supervisory Board Member (full-time)

    Outside Audit & Supervisory Board Member (full-time)

    Shunsuke Toyokawa
    1991
    Tsumura & Co.
    2010
    Director, Head of External Affairs Department, Tsumura & Co.
    2011
    General Manager, Head of External Affairs Department, Tsumura & Co.
    2013
    General Manager, Head of Audit & Supervisory Board Office, Tsumura & Co.
    2017
    General Manager, Head of Audit & Supervisory Committee Office, Tsumura & Co.
    2017
    General Manager, Internal Auditing Department, Tsumura & Co.
    2022
    Outside Audit & Supervisory Board Member (full-time), K Pharma Inc. (present)

Scientific Advisors

  • Kentaro Yoshimatsu

    Scientific Advisor

    Scientific Advisor

    Kentaro Yoshimatsu
    1978
    Eisai Co., Ltd.
    2003
    Division Director & Managing Officer, Drug Discovery Research Division, Eisai Co. Ltd.
    2006
    Managing Executive Officer, Eisai Co. Ltd.
    2006
    President, Eisai R&D Management Co., Ltd．
    2009
    Chief Scientific Officer & Managing Executive Officer, Eisai Co. Ltd.
    2010
    President, H3 Biomedicine Inc., Cambridge, US
    2011
    Senior Scientific Advisor, Eisai Co. Ltd.
    2018
    Scientific Advisor, K Pharma Inc. (present)
    2018
    President, RIN Institute Inc.
    2024
    Director, RIN Institute Inc. (present)

  • Atsushi Nakanishi

    Scientific Advisor

    Scientific Advisor

    Atsushi Nakanishi
    1986
    Takeda Pharmaceutical Company Limited
    1991
    Associate Research Head, Biotechnology Laboratories, Takeda Pharmaceutical Company Limited
    1997
    Research Head, Frontier Research Laboratories, Takeda Pharmaceutical Company Limited
    2001
    Director, Frontier Research Laboratories, Takeda Pharmaceutical Company Limited
    2006
    Project Manager, Regenerative Medicine Research Project, Frontier Research Laboratories, Takeda Pharmaceutical Company Limited
    2011
    Director, Biology Laboratories, Takeda Pharmaceutical Company Limited
    2013
    Director, Shonan Incubation Laboratory, Takeda Pharmaceutical Company Limited
    2017
    Director, T-CiRA Discovery, Takeda Pharmaceutical Company Limited
    2018
    Program Officer, Japan Agency for Medical Research and Development (present)
    2020
    Senior Research Advisor, T-CiRA Discovery, Takeda Pharmaceutical Company Limited
    2020
    Scientific Advisor, K Pharma Inc. (present)

  • Masato Yano

    Scientific Advisor

    Scientific Advisor

    Masato Yano
    2004
    Fellowship from Japan Society for the Promotion of Science
    2005
    Post-doctoral fellow, Fellowship from Japan Society for the Promotion of Science
    2006
    Instructor, Center of Excellence Program, Keio University School of Medicine, Tokyo
    2006
    Postdoctoral Associate, Department of Molecular Neuro-Oncology, The Rockefeller University
    2008
    Post-doctoral fellow, Fellowship from Japan Society for the Promotion of Science
    2010
    Postdoctoral Associate, The Rockefeller University
    2011
    Assistant Professor, Department of Physiology, Keio University School of Medicine
    2014
    Associate Professor, Niigata University Graduate School of Medical and Dental Sciences (present)
    2014
    Visiting Associate Professor, Department of Physiology, Keio University School of Medicine (present)
    2019
    Scientific Advisor, K Pharma Inc. (present)

Office

  • Headquarters

    Headquarters

    Tri-Seven Roppongi 8F, 7-7-7 Roppongi, Minato-ku, Tokyo 106-0032, Japan

    Google map
  • Research Facility

    Research Facility

    K Pharma Lab., Shonan iPark, 2-26-1 Muraoka Higashi, Fujisawa-shi, Kanagawa 251-8555, Japan

    Google map
  • Laboratory in Research Park on the Shinanomachi Campus of Keio University

    K Pharma-Keio Laboratory for Regenerative Medicine of SCI

    8S5, Integrated Medical Research Building, Keio University, 35, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan

    Google map

History

Nov., 2016
K Pharma Inc. established in Minato-ku, Tokyo, to research, develop, manufacture, and sell regenerative medicine and pharmaceutical products
Apr., 2018
Research facility opened in Shonan Health Innovation Park
Feb., 2023
「K Pharma-Keio Laboratory for Regenerative Medicine of SCI」 opened in the Integrated Medical Research Building on the Shinanomachi Campus of Keio University
NEXT
About K Pharma